Soretolide

Soretolide is an antiepileptic agent. Soretolide is effective in maximal electroshock-induced seizure (MES) test in rodents. Soretolide inhibits metabolism of Phenytoin (HY-B0448) . Soretolide exhibits a good pharmacokinetic character in rats model[1].

Product Specifications

CAS Number

[130403-08-6]

UNSPSC

12352005

Hazard Statement

H302-H315-H319

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/soretolide.html

Solubility

10 mM in DMSO

Smiles

CC1=CC(NC(C2=C(C)C=CC=C2C)=O)=NO1

Molecular Formula

C13H14N2O2

Molecular Weight

230.26

Precautions

P264-P270-P280-P302+P352-P330-P362+P364-P501

References & Citations

[1]Luszczki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep. 2009 Mar-Apr;61 (2) :197-216.